News

MTPA's oral therapy Radicava (edaravone) has shown decreased functional decline and improved survival in long-term ALS trials ...
Neurizon Therapeutics has reported positive topline results from an open-label extension (OLE) study of its lead candidate ...
Jodi O’Donnell-Ames founded Hope Loves Company to provide support, resources, and community to children affected by ALS.
By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in ...
The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...
The ketamine product KETARx made by PharmaTher has been approved by the FDA for use in surgical pain management.
By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in collaboration with ...
Retired industrial arts teacher Allen Mohr was said to have saved “a lot of kids from the scrap pile,” according to a former ...
The Japanese launch builds on ClearStrand-ASD’s successful rollout across the United States, where it is now available in 49 states. YAC Bio will partner with hospital systems in Japan to facilitate ...
ProSpec-Tany TechnoGene Ltd. (prospecbio), an internationally recognized manufacturer of recombinant proteins, today highlighted the groundbreaking p ...
The onset of motor neurone disease (MND) left Sarah without a voice and the use of her hands at the age of 34. It was within ...
Brain-computer interfaces (BCIs) are emerging as a groundbreaking technology that has the potential to revolutionize the way humans interact with machines. By bridging the gap between human cognition ...